GC-1130A

N/A

Report date: 2025/02/28 10:45:31

Base Information

Drug NameGC-1130A
Drug Alias NameRecombinant Human Heparan N-sulfataserhHNSGC1130AGC-1130ANP-3011
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionN-sulphoglucosamine sulphohydrolase modulators
TargetsN-sulphoglucosamine sulphohydrolase
Therapy Area/IndicationsMucopolysaccharidosis III
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth KoreaJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesNovel Pharma IncGC Biopharma Corp
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis III
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A